14 insiders reported 104 Form 4 transactions for CATALYST PHARMACEUTICALS, INC. (CPRX) over the past 18 months (most recent 2026-07-17). Recent activity: DENKHAUS DONALD A (Director) Sell 498,773 shares, Del Carmen Jeffrey (Chief Commercial Officer) Sell 14,337 shares, Miller Steve (Chief Op. & Scientific Officer) Sell 1.1M shares, Daly Richard J (President and CEO) Sell 271,266 shares, Andrews William T. (Chief Medical Officer) Sell 2,309 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | DENKHAUS DONALD A | Director | Sell | 498,773 | $15.7M |
| 2026-07-17 | Del Carmen Jeffrey | Chief Commercial Officer | Sell | 14,337 | $451,616 |
| 2026-07-17 | Miller Steve | Chief Op. & Scientific Officer | Sell | 1.1M | $34.5M |
| 2026-07-17 | Daly Richard J | President and CEO | Sell | 271,266 | $8.5M |
| 2026-07-17 | Andrews William T. | Chief Medical Officer | Sell | 2,309 | $72,734 |
| 2026-07-17 | Kalb Michael Wayne | Chief Financial Officer | Sell | 13,665 | $430,448 |
| 2026-07-17 | Elsbernd Brian | Chief Legal Officer | Sell | 242,501 | $7.6M |
| 2026-07-17 | Tierney David S | Director | Sell | 383,314 | $12.1M |
| 2026-07-17 | Thompson Tamar | Director | Sell | 3,773 | $118,850 |
| 2026-07-17 | Harper Molly | Director | Sell | 3,694 | $116,361 |
| 2026-07-17 | Sundaram Preethi | Chief Strategy Officer | Sell | 54,804 | $1.7M |
| 2026-07-17 | Russo Gregg | Chief HR Officer | Sell | 476 | $14,994 |
| 2026-07-17 | MCENANY PATRICK J | Director | Sell | 4.2M | $131.4M |
| 2026-06-05 | Andrews William T. | Chief Medical Officer | Buy | 3,052 | $0 |
| 2026-06-05 | Andrews William T. | Chief Medical Officer | Sell | 743 | $0 |
| 2026-02-19 | Russo Gregg | Chief HR Officer | Buy | 687 | $0 |
| 2026-02-19 | Russo Gregg | Chief HR Officer | Sell | 211 | $0 |
| 2026-01-06 | Kalb Michael Wayne | Executive Vice President & CFO | Buy | 7,139 | $0 |
| 2026-01-06 | Kalb Michael Wayne | Executive Vice President & CFO | Sell | 2,080 | $0 |
| 2026-01-06 | Daly Richard J | President and CEO | Sell | 10,577 | $0 |
| 2026-01-06 | Daly Richard J | President and CEO | Buy | 42,105 | $0 |
| 2025-12-30 | Daly Richard J | President and CEO | Sell | 524 | $0 |
| 2025-12-30 | Tierney David S | Director | Buy | 1,334 | $0 |
| 2025-12-30 | Harper Molly | Director | Buy | 1,334 | $0 |
| 2025-12-30 | Daly Richard J | President and CEO | Buy | 1,334 | $0 |
Source: SEC Form 4 filings · as of 2026-07-17